UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044228
Receipt number R000050511
Scientific Title Effect of daily ingestion of the test drink on HDL-cholesterol level
Date of disclosure of the study information 2021/06/30
Last modified on 2023/11/17 15:03:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of daily ingestion of the test drink on HDL-cholesterol level: A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Comparison Study

Acronym

Effect of daily ingestion of the test drink on HDL-cholesterol level

Scientific Title

Effect of daily ingestion of the test drink on HDL-cholesterol level

Scientific Title:Acronym

Effect of daily ingestion of the test drink on HDL-cholesterol level

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effect of intake of test drink on HDL-cholesterol level comparing to placebo drink.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

HDL-cholesterol level

Key secondary outcomes

Total cholesterol level, LDL-cholesterol level, triglyceride level, serum active ingredient level, skin carotenoid level


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Daily ingestion of 200 mL of juice containing active ingredient for 12 weeks

Interventions/Control_2

Daily ingestion of 200 mL of juice not containing active ingredient for 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1. Subjects who agree to participate in this study with a written informed consent
2. Subjects whose HDL-cholesterol level is >=35 mg/dL and <=60 mg/dL

Key exclusion criteria

1. Subjects who are under physician's advice, treatment, and/or medication for dyslipidemia and/or diabetes.
2. Subjects with familial hypercholesterolemia.
3. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities.
4. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc.
5. Subjects who have had allergic reactions to drugs or foods especially based on test food, Japanese cedar, Japanese cypress, or grass.
6. Subjects who regularly use medicines, health foods, and supplements.
7. Subjects who regularly take foods containing ingredients of test food.
8. Heavy smokers.
9. Alcohol addicts.
10. Subjects with disordered lifestyle.
11. Subjects with anemia.
12. Pre- or post-menopausal women complaining of obvious physical changes.
13. Pregnant or lactating women, women who expect to be pregnant during this study or may be pregnant.
14. Subjects who currently participate in other clinical trials or participated within the last 4 weeks prior to the current study.
15. Subjects who regularly exercise.
16. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Target sample size

270


Research contact person

Name of lead principal investigator

1st name Takuro
Middle name
Last name Inoue

Organization

KAGOME CO., LTD.

Division name

Innovation Division

Zip code

329-2762

Address

17 Nishitomiyama, Nasushiobara-shi, Tochigi, Japan

TEL

0287-36-2935

Email

Takuro_Inoue@kagome.co.jp


Public contact

Name of contact person

1st name Shigeru
Middle name
Last name Imai

Organization

Leverage Brain Inc.

Division name

Clinical Trial Department

Zip code

105-0004

Address

2-16-1 Shinbashi, Minato-ku, Tokyo, Japan

TEL

080-7290-0404

Homepage URL


Email

imai@levbrain.com


Sponsor or person

Institute

Leverage Brain Inc.

Institute

Department

Personal name



Funding Source

Organization

KAGOME CO.,LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Conference of Clinical Research

Address

1-13-23 Minamiikebukuro, Toshima-ku, Tokyo, Japan

Tel

03-6868-7022

Email

jccr-info@cts-smo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団 知正会 東京センタークリニック


Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 04 Month 23 Day

Date of IRB

2021 Year 05 Month 13 Day

Anticipated trial start date

2021 Year 07 Month 01 Day

Last follow-up date

2021 Year 12 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 05 Month 17 Day

Last modified on

2023 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050511


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name